Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
<strong>Background</strong> Tafenoquine, a single-dose therapy for Plasmodium vivax malaria, has been associated with relapse prevention through the clearance of P. vivax parasitemia and hypnozoites, termed “radical cure.” <strong>Methods</strong> We performed a phase 3, pro...
Main Authors: | Llanos-Cuentas, A, Lacerda, MVG, Hien, TT, Vélez, ID, Namaik-Larp, C, Chu, CS, Villegas, MF, Val, F, Monteiro, WM, Brito, MAM, Costa, MRF, Chuquiyauri, R, Casapía, M, Nguyen, CH, Aruachan, S, Papwijitsil, R, Nosten, FH, Bancone, G, Angus, B, Duparc, S, Craig, G, Rousell, VM, Jones, SW, Hardaker, E, Clover, DD, Kendall, L, Mohamed, K, Koh, GCKW, Wilches, VM, Breton, JJ, Green, JA |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Massachusetts Medical Society
2019
|
Similar Items
-
Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
by: St Jean, PL, et al.
Published: (2020) -
Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria
by: Lacerda, MVG, et al.
Published: (2019) -
Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
by: Watson, J, et al.
Published: (2018) -
Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
by: James Watson, et al.
Published: (2018-04-01) -
The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
by: Watson, JA, et al.
Published: (2022)